curcumin: Clinical Comparison of Application of Curcumin Gel in Pain Management After Free Gingival Graft Harvesting

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05819632
Collaborator
(none)
30
1
2
17
1.8

Study Details

Study Description

Brief Summary

The aim of this study is to compare the effect of using 2% curcumin gel versus gelatin sponge when applied to palatal donor site in pain management and wound healing after free gingival graft harvesting.

Condition or Disease Intervention/Treatment Phase
  • Other: curcumin gel 2%
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Clinical Comparison of Topical Application of Curcumin Gel Versus Gelatin Sponge in Pain Management and Wound Healing After Free Gingival Graft Harvesting: a Randomized Controlled Clinical Trial
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: curcumin gel

the denuded palatal area will be superficially covered with a continuous thin layer of curcumin gel 2% one time immediately after the surgery (curcumin gel will be prepared in 2% concentration on a carbapol base)according to (Bhatia et al., 2014)

Other: curcumin gel 2%
curcumin gel 2%

Active Comparator: gelatine sponge

absorbable gelatin sponge will be cut to the palatal wound size and applied. Following manual compression of the wound area, both agents will be secured in place using compressive palatal sling sutures. commercial name (CUTANPLAST)

Other: curcumin gel 2%
curcumin gel 2%

Outcome Measures

Primary Outcome Measures

  1. post-operative pain [one week post operative]

    post -operative pain measured by visual analouge scale from 0 (no pain) to 10 (highest pain value)

Secondary Outcome Measures

  1. Soft tissue healing of the palatal wound [up to three weeks post-operative]

    Soft tissue healing of the palatal wound measured by Modified Landry's wound healing score from 1 indicates poorest healing to 5 indicates excellent healing

  2. Re-epithelization of the palatal wound [up to three weeks post-operative]

    Re-epithelization of the palatal wound using H2O2 test

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Systematically healthy patient (American Society of Anesthesiology class I and II).

  2. Male or female

  3. Patients with mucogingival defects scheduled for free gingival graft.

  4. Patients with good oral hygiene.

Exclusion Criteria:
  1. Patients with any uncontrolled local or systemic disease where periodontal plastic surgery might be contraindicated.

  2. History of recent periodontal surgery at the donor site.

  3. Smokers.

  4. Pregnancy and lactation.

  5. Patients allergic to the used agents,

  6. Severe gagging reflex.

  7. Inability or unwillingness to provide informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry Cairo Manial Egypt 12311

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: tansim k abdelrahman, BDS, master student
  • Study Director: mohamed Atef, PHD, Lecture of oral medicine and periodontology, faculty of dentistry ,Cairo university
  • Study Chair: manal m hosny, phd, Professor of oral medicine and periodontology factuality of Dentistry,Cairo university

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tansim Khaled Tawfik Abdelrahman, masters degree candidate, Cairo University
ClinicalTrials.gov Identifier:
NCT05819632
Other Study ID Numbers:
  • CairoU28122022
First Posted:
Apr 19, 2023
Last Update Posted:
Apr 19, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2023